The Jackson Laboratory is excited to announce an opportunity for you to leverage our innovative HuPK™ (humanized FcRn) platform as part of your antibody-based therapeutic pipeline! We invite you to submit an entry form to be considered as a recipient of the JAX 2026 HuPK Preclinical Services Award of $15,000 USD applied toward a new HuPK Services project this year! Simply share with us a brief abstract describing your proposed project using the HuPK platform in your research study in order to be considered! *
*Terms & Conditions: The JAX 2026 HuPK Preclinical Services Award will be applied as a project credit of $15,000 USD toward a new project utilizing JAX Antibody Pharmacokinetics (FcRn) HuPK™ service. To participate, simply submit an entry form including a brief proposed research abstract (max. 500 words). Entries and abstracts will be reviewed by JAX Preclinical Services scientists to select an award recipient based on both feasibility and scientific merit of the proposed project. Our award recipient will be selected in July, 2026, with notification of award in August, 2026. The participant submission period begins March 15, 2026, and ends on June 30, 2026. The services award value of $15,000 must be applied to a new project, initiated by December 31, 2026, and may not be applied toward existing projects, currently underway with JAX.
Note: By submitting a participation form, you agree that should your lab be chosen to receive the JAX 2026 HuPK Preclinical Services Award, your abstract, as well as your name, institute name, and lab photo may be made public by JAX for marketing purposes to share the grant results with the scientific community.
